PRODUCT
首頁
產品資訊
PRODUCT
首頁
產品資訊
產品特點
| 編號 | 名稱 | 描述 | 純度 |
| HB1351 | A 769662 | Potent, reversible AMPK activator. Inhibits MSC proliferation | >98% |
| HB1883 | ABT 724 trihydrochloride | Potent dopamine D4receptor partial agonist | >99% |
| HB0099 | Acamprosate calcium | GABA receptor agonist and glutamergic modulator | |
| HB0100 | ACBC | Competitive NMDA receptor partial agonist | |
| HB3738 | AdipoRon | Adiponectin receptor (AdipoR) agonist | >98% |
| HB3298 | AdipoRon hydrochloride | AdipoR1 and AdipoR2 agonist | >98% |
| HB3741 | Aftin-4 | Roscovitine-related purine with no activity on CDKs. Roscovitine control. Increases Aβ42 production. | >98% |
| HB3742 | Aftin-5 | Roscovitine-related purine with no activity on CDKs. Roscovitine control. Increases Aβ42production. | >98% |
| HB2152 | AICAR | AMPK activator. Promotes osteogenic differentiation of bone marrow-derived MSCs. | >99% |
| HB0932 | Allopregnanolone | Potent GABAAreceptor positive allosteric modulator | |
| HB3751 | α-Galactosylceramide | Immunostimulant. Natural killer T cell stimulator. | >96% |
| HB0052 | (S)-AMPA | AMPA receptor agonist | >99% |
| HB0030 | (R,S)-AMPA | Prototypic AMPA receptor agonist | >98% |
| HB2023 | (±)-Anatoxin A fumarate | Potent nicotinic agonist | >96% |
| HB0116 | Aniracetam | Nootrophic AMPA receptor positive allosteric modulator | >99% |
| HB0370 | L-AP4 | L-AP4 is a selective group III mGluR agonist which inhibits synaptic transmission | >99% |
| HB1293 | Apoptosis Activator 2 | Caspase activator | >99% |
| HB0230 | D-Aspartic acid | NMDA receptor agonist | |
| HB0952 | (R)-Baclofen | Selective GABAB receptor agonist | >99% |
| HB0953 | (RS)-Baclofen | Selective GABAB receptor agonist | >99% |
| HB1209 | (±)-Bay K 8644 | L-type Ca2+channel agonist. Aids iPSCs generation from Mouse embryonic fibroblasts. | >99% |
| HB0133 | BINA | Potent, selective mGlu2positive allosteric modulator | >98% |
| HB1659 | BMY 7378 dihydrochloride | 5-HT1A partial agonist | |
| HB3101 | Bradykinin | Endogenous bradykinin receptors agonist | >95% |
| HB1664 | BRL 54443 | Potent 5-ht1E/1Freceptor agonist | |
| HB1649 | Buspirone hydrochloride | Classic 5-HT1A partial agonist | >99% |
| HB0154 | C2 Phytoceramide | Ceramide-activated protein phosphatase (CAPP) activator | |
| HB2785 | (-)-Cannabidiol | Nonpsychoactive cannabinoid found in cannabis | >98% |
| HB1179 | (E)-Capsaicin | TRPV1 channel agonist | >98% |
| HB0175 | CDPPB | Selective mGlu5positive allosteric modulator | >98% |
| HB3827 | cGAMP disodium | Potent STING ligand | >98% |
| HB0034 | (R,S)-CHPG sodium salt | Selective mGluR5agonist. Water soluble sodium salt | >99% |
| HB0033 | (R,S)-CHPG | Selective mGlu5agonist | >98% |
| HB2551 | Ciglitazone | Selective PPARγ agonist | >99% |
| HB0195 | Cinnabarinic acid | Selective mGlu4agonist | >98% |
| HB0197 | CIQ | GluN2C / GluN2D subunit selective NMDA receptor positive allosteric modulator | >98% |
| HB3839 | Citrinin | Mitochondrial permeability transition pore (MPTP) activator | >97% |
| HB1607 | Clozapine | Prototypic, atypical antipsychotic, binds to both serotonin and dopamine receptors | >99% |
| HB6129 | Clozapine dihydrochloride (water soluble) | Water soluble prototypic, atypical antipsychotic. Binds to both serotonin and dopamine receptors. | >98% |
| HB1807 | Clozapine N-oxide (CNO) (freebase) | Prototypical DREADD activator. Clozapine metabolite. | >98% |
| HB6149 | Clozapine N-oxide (CNO) dihydrochloride (water soluble) | Dihydrochloride salt of CNO - the prototypical DREADD activator | >98% |
| HB4888 | Compound 21 (DREADD agonist 21) | Highly potent hM3Dq DREADD agonist | >98% |
| HB6124 | Compound 21 (DREADD agonist 21) hydrochloride (water soluble) | Highly potent hM3Dq DREADD agonist. Water soluble. | >98% |
| HB3846 | Compound 112254 | Adiponectin receptor (AdipoR) agonist | >98% |
| HB3847 | Compound 112254 hydrochloride | Adiponectin receptor (AdipoR) agonist | >98% |
| HB2808 | Corticosterone | Endogenous gluococorticoid. MR and GR agonist. | >99% |
| HB1671 | CP 94253 hydrochloride | Potent, selective 5-HT1Breceptor agonist | >98% |
| HB0221 | Cyclothiazide | AMPA receptor positive allosteric modulator. Inhibits AMPAR desensitization. | >98% |
| HB1044 | CyPPA | Selective KCa2.2 / KCa2.3 activator | >99% |
| HB0380 | L-Cysteinesulfinic acid monohydrate | mGlu1α / mGlu5aagonist | |
| HB2033 | Cytisine | Potent, selective neuronal nicotinic agonist | >99% |
| HB3693 | (25S)-delta7-Dafachronic acid | Orphan nuclear receptor DAF-12 ligand | >95% |
| HB2488 | Daidzein | Estrogen receptors (ER) agonist. Phytoestrogen | >98% |
| HB2409 | DAMGO | Potent, selective μ-opioid receptor agonist | |
| HB2521 | Dexamethasone | Synthetic glucocorticoid. Induces hMSC differentiation | >98% |
| HB6020 | Dexamethasone (water-soluble) | Synthetic glucocorticoid with potent anti-inflammatory actions. Induces hMSC differentiation. Water soluble and suitable for cell culture | >98% |
| HB0045 | (S)-3,5-DHPG | Selective group I mGlu receptor agonist. Induces LTD | >99% |
| HB0026 | (R,S)-3,5-DHPG | Selective group I (mGluR1 / mGluR5) agonist | >99% |
| HB0244 | Diazoxide | Selective KIR6 activator | >98% |
| HB3876 | DMNQ | Cell-permeable, redox cycling quinone. Induces ROS generation. | >99% |
| HB2489 | DPN | Selective ERβ estrogen receptor agonist | >99% |
| HB2491 | DY131 | Novel selective estrogen-related receptor ERRβ and ERRγ agonist | >99% |
| HB1045 | 1-EBIO | Epithelial KCa channel activator. Promotes ESC differentiation into cardiomyocytes | >99% |
| HB2592) | EC 23 | Synthetic retinoid. Induces neural differentiation of hESCs | >99% |
| HB3731 | 6-ECDCA | Potent and selective FXR agonist | >95% |
| HB3881 | Ecdysone | Ecdysone receptor (EcR) agonist | >95% |
| HB1775 | Eletriptan hydrobromide | Selective 5-HT1B/1Dreceptor agonist | >99% |
| HB3887 | EM574 | Motilin receptor agonist | >95% |
| HB2410 | Endomorphin-1 | Potent, selective μ-opioid receptor agonist | |
| HB2411 | Endomorphin-2 | Potent, selective μ-opioid receptor agonist | |
| HB2494 | 17 β-Estradiol | Estrogen receptor (ER) agonist | >98% |
| HB0937 | Etomidate | Potent GABAAreceptor positive allosteric modulator | >99% |
| HB3895 | Ferulenol | Anti-tumor compound and tubulin polymerisation stimulator | >98% |
| HB0913 | FGIN-1-27 | Potent, selective MDR receptor agonist | >98% |
| HB3565) | FH 1 | iPSC-derived hepatocyte differentiation and maturation enhancer | >99% |
| HB1091 | Fluticasone propionate | Selective glucocorticoid receptor agonist | |
| HB1348 | Forskolin | Cell permeable, reversible adenylyl cyclase activator. Neuronal differentiation inducer | |
| HB3898 | FSL-1 | Toll-like receptor 2 (TLR2) and TLR6 agonist | |
| HB3899 | FTY720 hydrochloride | Potent sphingosine 1-phosphate (S1P) receptor (S1P1, S1P3, S1P4, and S1P5) agonist | >98% |
| HB0938 | Ganaxolone | Potent GABAAreceptor positive allosteric modulator | |
| HB3915 | Gardiquimod | Selective toll-like receptor 7 (TLR7) agonist | >98% |
| HB2775 | Genistein | Protein tyrosine kinase inhibitor and PPARγ agonist. Phytoestrogen | >98% |
| HB3918 | Geodin | Plasminogen activator (PAI-1) inhibitor | >95% |
| HB0383 | L-Glutamate | Glutamate receptor excitatory neurotransmitter | >99% |
| HB0243 | D-Glutamic acid | Endogenous NMDA receptor excitatory amino acid | |
| HB3920 | GV-58 | Selective N- and P/Q-type Ca2+-channel agonist | >97% |
| HB3921 | GW1929 | Potent, subtype-selective PPARγ agonist | >98% |
| HB2803 | Histamine dihydrochloride | Endogenous histamine receptor agonist | |
| HB1902 | Homovanillic acid | Fluorimetric reagent. Catecholamine metabolite. | >99% |
| HB3718 | 20-Hydroxyecdysone | Ecdysone receptor (EcR) agonist. More potent than Ecdysone | >95% |
| HB3933 | Hyperforin dicyclohexylammonium | Selective TRPC6 channel activator and neurotransmitter re-uptake inhibitor | >97% |
| HB0330 | Ibotenic acid | Non-selective NMDA / mGlu receptor agonist | >98% |
| HB1061 | ICA 069673 | Kv7.4 channel activator | >99% |
| HB1153 | Icilin | Potent TRPM8 channel agonist | >98% |
| HB3443 | ID 8 | Sustains ESC self-renewal and pluripotency | >99% |
| HB0334 | IDRA 21 | AMPA receptor positive allosteric modulator | >98% |
| HB3109 | Imiquimod | Toll-like receptor 7 (TLR7) agonist | >98% |
| HB0002 | (-)-Indolactam V | Synthetic PKC activator | >99% |
| HB1699 | Ipsapirone | Selective 5-HT1A agonist | >99% |
| HB3282 | IQ 1 | Wnt pathway activator. Maintains ESC pluripotency in Wnt3a treated cells. | >99% |
| HB0883 | Isoguvacine hydrochloride | Selective GABAA receptor agonist | >99% |
| HB4213 | Isoliquiritigenin | Flovonoid. Positive allosteric GABAA recetor modulator. | >97% |
| HB3401 | ISX 9 | Neurogenic agent. Induces SVZ progenitor neuronal differentiation and cardiomyogenic differentiation | >99% |
| HB0355 | Kainic acid | Prototypic, selective kainate receptor agonist. Potent excitant and neurotoxin | >98% |
| HB3248 | Kartogenin | Potently induces chondrogenesis in MSCs | >98% |
| HB1925 | L-DOPA | Immediate precursor of dopamine | >98% |
| HB0385 | Loperamide hydrochloride | Potent, selective µ-opioid receptor agonist | >99% |
| HB0877 | MEDICA 16 | Free fatty acid 1 (FFA1) receptor agonist | |
| HB2622 | Mepyramine maleate | Selective H1 receptor inverse agonist | |
| HB2153 | Metformin hydrochloride | LKB1/AMPK activator. Also promotes neurogenesis. | |
| HB1658 | Mianserin hydrochloride | Non-selective 5-HT2 receptor antagonist. Shows activity at other receptors. | >99% |
| HB1094 | Minoxidil | Kir6 channel activator | >99% |
| HB1064 | ML 213 | Selective Kv7.2 / Kv7.4 channel activator | >99% |
| HB3981 | Monosodium urate (ready-to-use) | NLRP3/NALP3 inflammasome activator | |
| HB1737 | Mosapride citrate | 5-HT4 receptor agonist. Also 5-HT3 antagonist. | >99% |
| HB4632 | MOTS-c (human) | Promotes AICAR and downstream (AMPK) biosynthesis | >95% |
| HB1782 | MS 245 oxalate | 5-HT6 antagonist | >99% |
| HB3985 | Muristerone A | Ecdysone receptor (EcR) agonist. Apoptosis inducer | >95% |
| HB0887 | Muscimol | Potent, selective, competitive GABAA receptor agonist | >99% |
| HB3105 | Neuropathiazol | Selective neuronal differentiation inducer in hippocampal neural progenitors | >98% |
| HB3997 | NG 012 | Nerve growth factor (NGF) potentiator | >95% |
| HB0454 | NMDA | Prototypic NMDA receptor agonist | >99% |
| HB1048 | NS 1619 | Potent, selective KCa1.1 channel activator | >98% |
| HB1066 | NS 1643 | Kv11.1 channel activator | >98% |
| HB1049 | NS 309 | Potent, selective KCa3.1 / KCa2 channel subfamily activator | >98% |
| HB3391 | OAC-1 | Oct4 activator. Enhances iPSC reprogramming efficiency. | >98% |
| HB4004 | OCH | iNKT cell glycolipid agonist | >95% |
| HB0475 | O-Phospho-L-serine | Group III mGlu agonist | |
| HB1291 | PAC 1 | Procaspase-activating compound | >98% |
| HB4015 | Pam3Cys-Ser-(Lys)4 trihydrochloride | Selective Toll-like receptor1/2 (TLR1/TLR2) complex agonist | |
| HB1749 | Pemoline | CNS stimulant. Indirect monoamine agonist. | >99% |
| HB0482 | PEP 005 | Broad spectrum PKC agonist | >98% |
| HB6126 | Perlapine hydrochloride (water soluble) | Novel, potent and selective hM3Dq DREADD receptor agonist. Water soluble | >98% |
| HB4889 | Perlapine | Novel, potent and selective hM3Dq DREADD receptor agonist | >98% |
| HB1292 | PETCM | Caspase-3 activator | >99% |
| HB2831 | 1-Phenylbiguanide hydrochloride | 5-HT3 receptor agonist | |
| HB0502 | Phorbol 12-myristate 13-acetate (PMA) | PKC activator | >99% |
| HB2478 | Pifithrin-α hydrobromide | p53 inhibitor and Aryl hydrocarbon receptor agonist. Supresses ESC self renewal. | >98% |
| HB2554 | Pioglitazone hydrochloride | Selective PPARγ agonist | >99% |
| HB4139 | Pioglitazone | Selective PPARγ agonist | >98% |
| HB4029 | Piperafizine B | Analog of Piperafizine A. Potentiator of vincristine cytotoxicity. | >98% |
| HB0507 | Piracetam | GABA derivative AMPA positive allosteric modulator | |
| HB1243 | α-Pompilidotoxin | Voltage-gated Na+ channel activator | |
| HB4033 | Ponasterone A | Ecdysone receptor (EcR) agonist | >95% |
| HB2499 | PPT | Selective ERα estrogen receptor agonist | >99% |
| HB1933 | Pramipexole dihydrochloride | Selective D3 receptor agonist | >99% |
| HB3460 | Prostaglandin E2 | Endogenous prostanoid. Induces hematopoietic stem cell proliferation. | >98% |
| HB0544 | Quinolinic acid | Endogenous NMDA receptor agonist | |
| HB0387 | L-Quisqualic acid | AMPA receptor agonist / group I mGlu agonist | >99% |
| HB1185 | Resiniferatoxin | Potent TRPV1 channel agonist | >98% |
| HB1186 | RN 1747 | Selective TRPV4 agonist | |
| HB1923 | Ropinirole | Selective D2-like receptor agonist | >99% |
| HB2556 | Rosiglitazone | Potent and selective PPARγ agonist. Promotes adipocyte differentiation and enhances NPC proliferation. | >99% |
| HB4140 | Rosiglitazone maleate | Potent and selective PPARγ agonist; antidiabetic agent. | >98% |
| HB1927 | Rotigotine hydrochloride | Dopamine D2 and D3 receptor agonist | >99% |
| HB3107 | SAG | Cell permeable Sonic hedgehog (Shh) agonist and Smo agonist. Enhances neuronal differentiation. | >98% |
| HB4070 | SAG Analog (highly active) | Highly active Sonic hedgehog agonist. Also smoothened (Smo) agonist. | >98% |
| HB4071 | SAG Analog (LowTox) | Low toxicity Sonic hedgehog agonist. Also smoothened (Smo) agonist. | >98% |
| HB4887 | Salvinorin B (SALB) | Potent, selective KORD DREADD activator | >98% |
| HB1756 | SB 399885 hydrochloride | Potent 5-HT6 antagonist | >99% |
| HB0267 | D-Serine | NMDA receptor co-agonist | |
| HB1050 | SKA 31 | KCa3.1 channel / KCa2 channel subfamily activator | >99% |
| HB6111 | SKF 38393 hydrochloride | Prototypic, selective D1-like receptor partial agonist | >98% |
| HB1840 | SKF 38393 hydrobromide | Prototypic, selective D1-like receptor partial agonist | >98% |
| HB1858 | SKF 81297 hydrobromide | D1-like receptor agonist | >98% |
| HB0954 | SKF 97541 | Potent GABAB receptor agonist | |
| HB1172 | SN 2 | Selective TRPML3 channel activator | >98% |
| HB0585 | Spaglumic acid | Selective mGlu3 agonist, peptide neurotransmitter | >96% |
| HB0586 | Spermidine hydrochloride | nNOS inhibitor / PTPN2activator | |
| HB3424 | Strontium chloride | Calcium sensing receptor (CaSR) agonist. Induces MSC osteogenic differentiation. | |
| HB1769 | Sumatriptan succinate | 5-HT1D, 5-HT1B and 5-HT1A receptor agonist | >99% |
| HB1704 | Tianeptine sodium salt | Selective 5-HT uptake enhancer | >99% |
| HB2559 | Troglitazone | Potent, selective PPARγ agonist. Inhibits hematopoietic cell line growth. | >97% |
| HB6158 | UBP684 | Novel NMDAR pan-PAM | >98% |
| HB4118 | Umbellulone | Selective TRPA1 activator | >98% |
| HB1006 | Veratridine | Na+ channel activator | >98% |
| HB1498 | VU 0357017 hydrochloride | Potent, selective M1 receptor allosteric agonist | >98% |
| HB0638 | VU 0361737 | mGlu4 positive allosteric modulator | >99% |
| HB0639 | VU 0364439 | Potent mGlu4 positive allosteric modulator | >99% |
| HB0640 | VU 0364770 | mGlu4 positive allosteric modulator | >99% |
| HB0642 | VU 29 | Potent mGlu5 positive allosteric modulator | >98% |
| HB0659 | Xanthurenic acid | Endogenous group II mGlu agonist | >98% |
| HB3521 | YC-1 | Guanylyl cyclase activator. Also induces G1 cell cycle arrest. | >98% |
| HB2517 | Zearalenone | Estrogen receptor agonist | >98% |
| HB1801 | Zolmitriptan | Potent 5-HT1B/1D/1F agonist | >99% |